rewirebio.iobenchmarks
Protocol

Lancet paper virtual-tumor SNV/indel benchmark

Lancet paper virtual-tumor SNV/indel benchmark; bounded primary-source AMP candidate.

2 evaluations · 24 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

2 recorded evaluations, 24 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.

View coverage and remaining gaps across all benchmarks

Results

Results are available, but no reviewed comparison panel is linked in this release.

All evaluations

2 evaluations · 24 results. Different protocols are not a single leaderboard.

Protocol: Lancet paper virtual-tumor SNV/indel benchmark · Dataset: NA12892/NA12891 virtual tumor and matched normal

Sorted by F1 (indel only) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationF1 (indel only)F1 (SNV only)False negatives (indel only)False negatives (SNV only)False positives (indel only)False positives (SNV only)Precision (indel only)Precision (SNV only)Recall (indel only)Recall (SNV only)True positives (indel only)True positives (SNV only)
LancetEvaluation0.81 (best in column)0.85 (best in column)13597744305 (best in column)565 (best in column)0.92 (best in column)0.98 (best in column)0.720.75358623,848
Strelka2Evaluation0.770.85 (best in column)1298 (best in column)7460 (best in column)86711170.810.960.73 (best in column)0.76 (best in column)3647 (best in column)24,132 (best in column)
All 24 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.81 F1 (indel only)
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Lancet row (JATS Tab1)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
1360 False negatives (indel only)
count · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Lancet row (JATS Tab1)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
305 False positives (indel only)
count · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Lancet row (JATS Tab1)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.92 Precision (indel only)
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Lancet row (JATS Tab1)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.72 Recall (indel only)
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Lancet row (JATS Tab1)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
3590 True positives (indel only)
count · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Lancet row (JATS Tab1)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.85 F1 (SNV only)
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Lancet row (JATS Tab2)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
7740 False negatives (SNV only)
count · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Lancet row (JATS Tab2)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
565 False positives (SNV only)
count · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Lancet row (JATS Tab2)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.98 Precision (SNV only)
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Lancet row (JATS Tab2)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.75 Recall (SNV only)
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Lancet row (JATS Tab2)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
23,848 True positives (SNV only)
count · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Lancet row (JATS Tab2)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.77 F1 (indel only)
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Strelka2 row (JATS Tab1)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
1300 False negatives (indel only)
count · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Strelka2 row (JATS Tab1)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
867 False positives (indel only)
count · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Strelka2 row (JATS Tab1)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.81 Precision (indel only)
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Strelka2 row (JATS Tab1)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.73 Recall (indel only)
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Strelka2 row (JATS Tab1)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
3650 True positives (indel only)
count · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Strelka2 row (JATS Tab1)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.85 F1 (SNV only)
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Strelka2 row (JATS Tab2)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
7460 False negatives (SNV only)
count · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Strelka2 row (JATS Tab2)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
1120 False positives (SNV only)
count · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Strelka2 row (JATS Tab2)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.96 Precision (SNV only)
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Strelka2 row (JATS Tab2)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.76 Recall (SNV only)
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Strelka2 row (JATS Tab2)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
24,132 True positives (SNV only)
count · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Strelka2 row (JATS Tab2)

Source checking is not independent reproduction. Release 2026-11-21-adc15377fab2.

Methods and evaluation design

Procedure, tasks and evaluated configurations

Recorded evaluations

Each evaluation records what was tested and under which conditions.

Baseline coverage

Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.

0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.

No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.

Author-reported evaluations
1
External evaluations
1

Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.

Null control

Proposed control: requires review

Select a task-valid null control after reviewing inputs and metric

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Conventional reference

Proposed control: requires review

Select an upstream conventional reference after reviewing the full protocol

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)

Coverage is derived from release 2026-11-21-adc15377fab2. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.

Run instructions

No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID amp-oncology-rna-20261007-protocol-lancet-virtual-tumor.

Related records

Suggest a correction